TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Rhythm Biosciences Ltd. ( (AU:RHY) ) is now available.
Rhythm Biosciences Ltd. announced the issuance of 2,700,000 unquoted equity securities in the form of options expiring on November 30, 2027, with an exercise price of $0.20. This issuance, part of an employee incentive scheme, reflects the company’s strategic efforts to align employee interests with long-term growth objectives, potentially impacting its operational dynamics and market positioning.
The most recent analyst rating on (AU:RHY) stock is a Hold with a A$0.09 price target. To see the full list of analyst forecasts on Rhythm Biosciences Ltd. stock, see the AU:RHY Stock Forecast page.
More about Rhythm Biosciences Ltd.
Rhythm Biosciences Ltd. operates in the biotechnology industry, focusing on developing and commercializing medical diagnostics. The company is known for its innovative solutions aimed at early detection of cancer and other diseases, positioning itself as a significant player in the healthcare diagnostics market.
Average Trading Volume: 343,535
Technical Sentiment Signal: Buy
Current Market Cap: A$28.99M
Learn more about RHY stock on TipRanks’ Stock Analysis page.